Pharmanutra S.p.A. (BIT:PHN)

Pharmanutra Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.16	18.58	15.49	18.93	22.05	29.41
Short-Term Investments	7.84	12.04	13.48	6.19	4.81	4.53
Cash & Short-Term Investments	29	30.62	28.97	25.12	26.86	33.94
Cash Growth	-5.71%	5.67%	15.34%	-6.49%	-20.86%	63.14%
Accounts Receivable	28.26	24.76	22.05	19.22	21.65	16.67
Other Receivables	0.53	2.43	2.1	2.7	2.12	0.99
Receivables	28.79	27.2	24.15	21.92	23.77	17.66
Inventory	8.48	8.85	6.94	8.17	5.26	2.87
Prepaid Expenses	-	2.1	0.68	1.06	0.93	0.15
Other Current Assets	8.39	4.14	4.26	2.42	1.9	0.9
Total Current Assets	74.67	72.9	65.01	58.68	58.73	55.52
Property, Plant & Equipment	24.07	24.13	25.66	26.36	17.06	8.37
Long-Term Investments	0	0	0	0	0	0.25
Goodwill	-	17.56	17.56	17.56	17.56	2.75
Other Intangible Assets	24.66	3.81	3.71	3.73	3.15	2.45
Long-Term Deferred Tax Assets	2.48	2.15	1.4	1.52	1.31	1.24
Long-Term Deferred Charges	-	0.68	0.67	0.08	-	-
Other Long-Term Assets	2.24	3.99	3.39	4.5	2.36	0.77
Total Assets	128.13	125.23	117.41	112.44	100.16	71.36

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	17.52	17.36	13.5	13.66	14.89	8.49
Accrued Expenses	-	4.19	3.81	3.23	2.83	2.6
Short-Term Debt	0.13	0.6	0.41	0.63	-	-
Current Portion of Long-Term Debt	4.09	4.06	4.04	3.59	3.37	0.56
Current Portion of Leases	0.44	0.41	0.32	0.37	0.25	0.26
Current Income Taxes Payable	3.86	0.89	1.96	2.18	0.98	2.92
Current Unearned Revenue	-	2.54	2.3	2.45	2	1.26
Other Current Liabilities	5.36	0.99	1.02	1.55	1.48	0.66
Total Current Liabilities	31.4	31.03	27.34	27.65	25.79	16.75
Long-Term Debt	13.32	14.35	18.15	22.19	13.61	5
Long-Term Leases	1.12	1.1	1.36	1.24	0.5	0.53
Pension & Post-Retirement Benefits	6.13	1.36	1.33	1.21	1.07	2.52
Other Long-Term Liabilities	1.69	6.15	7.09	5.75	8.23	1.48
Total Liabilities	53.65	53.99	55.27	58.04	49.21	26.27

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.12	1.12	1.12	1.12	1.12	1.12
Retained Earnings	3.46	20	16.61	12.83	15.27	14
Treasury Stock	-5.9	-5.9	-4.56	-4.01	-	-
Comprehensive Income & Other	75.79	56.01	48.97	44.47	34.55	29.96
Shareholders' Equity	74.47	71.24	62.14	54.41	50.95	45.08
Total Liabilities & Equity	128.13	125.23	117.41	112.44	100.16	71.36

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	19.1	20.51	24.27	28.02	17.73	6.35
Net Cash (Debt)	9.91	10.1	4.7	-2.9	9.14	27.59
Net Cash Growth	47.74%	114.91%	-	-	-66.89%	44.14%
Net Cash Per Share	1.04	1.05	0.49	-0.30	0.94	2.85
Filing Date Shares Outstanding	9.6	9.58	9.6	9.61	9.62	9.68
Total Common Shares Outstanding	9.6	9.58	9.6	9.61	9.64	9.68
Working Capital	43.28	41.87	37.67	31.03	32.94	38.77
Book Value Per Share	7.76	7.44	6.47	5.66	5.28	4.66
Tangible Book Value	49.82	49.87	40.86	33.11	30.24	39.88
Tangible Book Value Per Share	5.19	5.21	4.26	3.44	3.14	4.12
Land	-	20.74	20.65	20.42	0.75	0.64
Machinery	-	8.08	7.61	6.86	3.26	2.85
Construction In Progress	-	0.31	0.16	0.13	14.92	6.14

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error